E. M. O' Reilly

FOLFIRINOX as Initial Treatment for Localized Pancreatic Adenocarcinoma: A Retrospective Analysis by the Trans-Atlantic Pancreatic Surgery Consortium

W. Jarnagin, C. V. van Eijck, M. Katz, 2022, Journal of the National Cancer Institute.

A randomized phase III trial of DX-8951f (Exatecan Mesylate; DX) and Gemcitabine (GEM) vs. Gemcitabine alone in advanced pancreatic cancer (APC).

G. Abou-Alfa, H. Hurwitz, N. S. Tchekmedyian, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.